Class III isolator Cytobox Light
floor-standingEN 12469negative pressure

class III isolator
class III isolator
Add to favorites
Compare this product
 

Characteristics

Class
class III
Configuration
floor-standing
Certifications
EN 12469
Other characteristics
negative pressure
Sound level

54 dB, 57 dB

External width

1,350 mm, 1,655 mm, 1,960 mm
(53.15 in, 65.16 in)

External depth

882 mm
(34.72 in)

External height

2,345 mm
(92.32 in)

Internal width

1,473 mm, 1,778 mm
(57.99 in, 70 in)

Internal depth

580 mm
(22.83 in)

Internal height

740 mm
(29.13 in)

Weight

315 kg, 350 kg, 400 kg
(694.46 lb, 771.62 lb, 881.85 lb)

Description

CYTOBOX LIGHT cytotoxic isolators are negative pressure glove boxes with pass boxes integrated into the work surface. They are used to separate a pharmaceutical process or activity from both the operator and the surrounding environment in the case of reconstituting freeze-dried drugs and handling toxic materials. Designed for the safe preparation and handling of hazardous substances such as cytotoxic drugs and safe handling of antineoplastic chemotherapy drugs and CMR substances. CYTOBOX LIGHT is an isolator system designed primarily for the reconstitution of antineoplastic drugs. It operates under negative pressure offering triple protection to the operator, environment and product. Gloves installed on the front screen provide physical separation of the products being handled, ensuring greater safety for operators. CYTOBOX LIGHT can also be used for the handling of pathogens belonging to any group according to EN 12469: 2000 and whenever the process involves the handling of cytotoxic or hazardous chemicals. The unit is equipped with triple-level HEPA filtration CYTOBOX LIGHT can be used in various ways in hospital oncology centers for the preparation of drugs and whenever a high and proven degree of protection for operators is required. In particular, the isolator is suitable for the following applications: preparation of antineoplastic chemotherapy drugs, handling of cytotoxic and cytostatic drugs, handling of aetiological agents of proven and active pathogenicity in humans and animals, handling of highly concentrated pathogenic compounds and mutagenic agents, oncogenic viruses,

Exhibitions

Meet this supplier at the following exhibition(s):

MEDICA 2024
MEDICA 2024

11-14 Nov 2024 Düsseldorf (Germany) Hall 1 - Stand D01

  • More information
    *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.